Liu Shanglei, Jacobsen Garth R, Sandler Bryan J, Savides Thomas J, Fehmi Syed, Fuchs Hans, Luo Ran B, Delong Jonathan C, Coker Alisa M, Houghton Caitlin, Horgan Santiago
1 Department of Surgery, Center for the Future of Surgery, University of California at San Diego , San Diego, California.
2 Department of Gastroenterology, University of California at San Diego , San Diego, California.
J Laparoendosc Adv Surg Tech A. 2018 Apr;28(4):439-444. doi: 10.1089/lap.2017.0167. Epub 2018 Feb 12.
Over-the-scope-clip (OTSC) System is a relatively new endoluminal intervention for gastrointestinal (GI) leaks, fistulas, and bleeding. Here, we present a single center experience with the device over the course of 4 years.
Retrospective chart review was conducted for patients who received endoscopic OTSC treatment. Primary outcome is the resolution of the original indication for clip placement. Secondary outcomes are complications and time to resolution.
Forty-one patients underwent treatment with the OTSC system from 2011 to 2015 with average follow-up of 152 days. The average age is 53.7. The most common site of clip placement was in the stomach (44%). Clips were placed after surgical complication for 28 patients (68%), endoscopic complications for 8 patients (19%), and spontaneous presentation in 5 patients (12%). Technical success was achieved in all patients. Overall, 34 patients (83%) were successfully treated. Nine patients required multiple clips and three patients required additional treatment modalities after OTSC. Four patients used the OTSC as a bridging therapy to surgery. Using OTSC for palliation versus nonpalliative indications was associated with lower rates of treatment success (50% versus 86%, P = .028). Using OTSC for symptoms <6 months had higher rates of treatment success than those experiencing longer symptoms (88% versus 65%, P = .045). There were no major morbidities or mortalities directly associated with the OTSC system. Complications from clip use were pain in two patients (5%) and hematemesis in one patient (3%).
The OTSC System can be a very successful treatment for iatrogenic or spontaneous GI leaks and bleeds. Treatment success is more likely in patients treated within 6 months of diagnosis and less likely to when used for palliation. It was also successfully used as bridging therapy in several patients.
内镜下圈套夹(OTSC)系统是一种相对较新的用于治疗胃肠道(GI)漏、瘘和出血的腔内干预手段。在此,我们介绍本中心在4年期间使用该设备的经验。
对接受内镜OTSC治疗的患者进行回顾性病历审查。主要结局是夹子放置的原始指征得到解决。次要结局是并发症和解决时间。
2011年至2015年,41例患者接受了OTSC系统治疗,平均随访152天。平均年龄为53.7岁。夹子放置最常见的部位是胃(44%)。28例患者(68%)在手术并发症后放置夹子,8例患者(19%)在内镜并发症后放置夹子,5例患者(12%)为自发情况。所有患者均取得技术成功。总体而言,34例患者(83%)得到成功治疗。9例患者需要多个夹子,3例患者在OTSC治疗后需要其他治疗方式。4例患者将OTSC用作手术的桥接治疗。将OTSC用于姑息治疗与非姑息治疗指征相比,治疗成功率较低(50%对86%,P = 0.028)。使用OTSC治疗症状<6个月的患者比症状持续时间较长的患者治疗成功率更高(88%对65%,P = 0.045)。没有与OTSC系统直接相关的重大发病或死亡情况。使用夹子的并发症包括2例患者疼痛(5%)和1例患者呕血(3%)。
OTSC系统对于医源性或自发性GI漏和出血可能是一种非常成功的治疗方法。在诊断后6个月内接受治疗的患者治疗成功的可能性更大;用于姑息治疗时成功的可能性较小。它还在数例患者中成功用作桥接治疗。